Josephine Salimu

696 citations
11 papers · 406 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)Adenosine and Purinergic Signaling (2 papers)

In The Last Decade

Josephine Salimu

11 papers receiving 405 citations

Peers

Josephine Salimu
Comparison fields: 5 of 55
  • Molecular Biology 228
  • Immunology 167
  • Oncology 145
  • Cancer Research 134
  • Pulmonary and Respiratory Medicine 54
Replace Hussein Shehade with:
Hussein Shehade United States
Pratha Budhani United States
Priska Auf der Maur Switzerland
Céline Rodriguez France
Mohammad Awaji Saudi Arabia
Changfa Qu China
Jonathan H. Law United States
Yiyi Liang China
Sanja Pečanić Croatia
Majdi Maiel France
Josephine Salimu relative to Hussein Shehade United States Hussein Shehade's profile →
Citations per field
00.5×1.5×2.5×
Hussein Shehade · 1×
Citations per year

Countries citing papers authored by Josephine Salimu

Since Specialization
Citations

This map shows the geographic impact of Josephine Salimu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josephine Salimu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josephine Salimu more than expected).

Fields of papers citing papers by Josephine Salimu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josephine Salimu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josephine Salimu. The network helps show where Josephine Salimu may publish in the future.

Co-authorship network of co-authors of Josephine Salimu

This figure shows the co-authorship network connecting the top 25 collaborators of Josephine Salimu. A scholar is included among the top collaborators of Josephine Salimu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josephine Salimu. Josephine Salimu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 111
5 129
6 15
7 34
8 57
9 26
10 1
11 29

About Josephine Salimu

Josephine Salimu is a scholar working on Physiology, Immunology and Oncology, having authored 11 papers that have together received 406 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Cancer Research (134 citations), Immunology (167 citations) and Physiology (34 citations). Josephine Salimu has collaborated with scholars based in United Kingdom, Canada and Ireland. Frequent co-authors include Aled Clayton, Zsuzsanna Tabi, Saly Al‐Taei, Jason Webber, Mark Gurney, Malcolm D. Mason, Lisa K. Spary, John Crown, Lorraine O’Driscoll and Vanesa G. Martínez. Their work appears in journals such as The Journal of Immunology, Cancer Research and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026